OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
Julia Koerner, Dennis J. Horvath, Valerie L. Herrmann, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 255

Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80

Reprogramming Mitochondrial Metabolism in Synovial Macrophages of Early Osteoarthritis by a Camouflaged Meta‐Defensome
Lei Zhang, Xiang Chen, Pingqiang Cai, et al.
Advanced Materials (2022) Vol. 34, Iss. 30
Closed Access | Times Cited: 70

Emerging biomaterials for tumor immunotherapy
Minna Xiao, Qinglai Tang, Shiying Zeng, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 39

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
Bowen Lu, Jing Ming Lim, Boyue Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 32

The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
Xue Chen, Yunxiao Zhang, Yao Fu
Medicine in Drug Discovery (2022) Vol. 14, pp. 100122-100122
Open Access | Times Cited: 52

Polymeric nanoparticle-based nanovaccines for cancer immunotherapy
Yongxin Zhang, Jiajing Chen, Linqi Shi, et al.
Materials Horizons (2022) Vol. 10, Iss. 2, pp. 361-392
Closed Access | Times Cited: 48

Engineered extracellular vesicles: potentials in cancer combination therapy
Jiangbin Chen, Qi Tan, Zimo Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43

Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy
Pei Pei, Yu Zhang, Yunchun Jiang, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 11325-11337
Closed Access | Times Cited: 40

MnO2-melittin nanoparticles serve as an effective anti-tumor immunotherapy by enhancing systemic immune response
Shupei Tang, Zhou Lan, Haiyang He, et al.
Biomaterials (2022) Vol. 288, pp. 121706-121706
Closed Access | Times Cited: 37

Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy
Tasneem Abaza, Mostafa K. Abd El‐Aziz, Kerolos Ashraf Daniel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16484-16484
Open Access | Times Cited: 31

Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 30

Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy
Huali Lei, Quguang Li, Zifan Pei, et al.
Small (2023) Vol. 19, Iss. 45
Open Access | Times Cited: 26

Comb-structured mRNA vaccine tethered with short double-stranded RNA adjuvants maximizes cellular immunity for cancer treatment
Theofilus A. Tockary, Saed Abbasi, Miki Matsui-Masai, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 29
Open Access | Times Cited: 26

Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 26

PLGA Particles in Immunotherapy
Dennis J. Horvath, Michael Basler
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 615-615
Open Access | Times Cited: 25

Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 23

CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity
Lulu Yu, Qi Xiao, Bing Yu, et al.
Cancer Letters (2023) Vol. 564, pp. 216219-216219
Open Access | Times Cited: 22

Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers‐Mediated Photodynamic Therapy
Qing Yu, Xia Li, Juan Wang, et al.
Small (2023) Vol. 20, Iss. 16
Closed Access | Times Cited: 21

Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11

Machine learning assisted exploration of the influential parameters on the PLGA nanoparticles
Sima Rezvantalab, Sara Mihandoost, Masoumeh Rezaiee
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

Quantitative Label-Free Chemical Imaging of PLGA Nanoparticles in Cells and Tissues with Single-Particle Sensitivity
Xin Gao, Xiaoqi Lang, Elsy El Khoury, et al.
Nano Letters (2024) Vol. 24, Iss. 3, pp. 1024-1033
Closed Access | Times Cited: 6

Engineering Self-Assembling Peptide Hydrogel to Enhance the Capacity of Dendritic Cells to Activate In Vivo T-Cell Immunity
Ruyue Luo, Yuan Wan, Guicen Liu, et al.
Biomacromolecules (2024) Vol. 25, Iss. 3, pp. 1408-1428
Closed Access | Times Cited: 6

Recent Applications of PLGA in Drug Delivery Systems
Jie Yang, Huiying Zeng, Yusheng Luo, et al.
Polymers (2024) Vol. 16, Iss. 18, pp. 2606-2606
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top